You can find more information about PF3D7_1365600-Topoisomerase IV using the following links:

Subcellular Localization

• Picture 1
• Picture 2
• Picture 3

Affecting Drugs
Drug Name	PubMed Articles (year of publication)
(2Z,4Z)-11-([1,1'-biphenyl]-3-yl)-9-([1,1'-biphenyl]-4-yl)-8-chloro-14-methyl-14,14a-dihydrobenzo[c]oxireno[2,3-k][1]oxacyclotridecine-6,12(1aH,7H)-dione	Molecular docking and molecular dynamics simulation identify a novel Radicicol derivative that predicts exclusive binding to Plasmodium falciparum Topoisomerase VIB(2021)
ciprofloxacin	Enhancement of the antimalarial activity of ciprofloxacin using a double prodrug/bioorganometallic approach(2009)
etoposide	Radicicol-Mediated Inhibition of Topoisomerase VIB-VIA Activity of the Human Malaria Parasite Plasmodium falciparum(2016)
Fluoroquinolone	Enhancement of the antimalarial activity of ciprofloxacin using a double prodrug/bioorganometallic approach(2009)
In silico, suggested target	In silico prediction of antimalarial drug target candidates(2012)
Radicicol	Radicicol confers mid-schizont arrest by inhibiting mitochondrial replication in Plasmodium falciparum(2014) Radicicol-Mediated Inhibition of Topoisomerase VIB-VIA Activity of the Human Malaria Parasite Plasmodium falciparum(2016)